These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 26384859)

  • 1. Cinnamamides, Novel Liver X Receptor Antagonists that Inhibit Ligand-Induced Lipogenesis and Fatty Liver.
    Sim WC; Kim DG; Lee KJ; Choi YJ; Choi YJ; Shin KJ; Jun DW; Park SJ; Park HJ; Kim J; Oh WK; Lee BH
    J Pharmacol Exp Ther; 2015 Dec; 355(3):362-9. PubMed ID: 26384859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LXR-α antagonist meso-dihydroguaiaretic acid attenuates high-fat diet-induced nonalcoholic fatty liver.
    Sim WC; Park S; Lee KY; Je YT; Yin HQ; Choi YJ; Sung SH; Park SJ; Park HJ; Shin KJ; Lee BH
    Biochem Pharmacol; 2014 Aug; 90(4):414-24. PubMed ID: 24955981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 20(S)-protopanaxatriol inhibits liver X receptor α-mediated expression of lipogenic genes in hepatocytes.
    Oh GS; Yoon J; Lee GG; Oh WK; Kim SW
    J Pharmacol Sci; 2015 Jun; 128(2):71-7. PubMed ID: 26109499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Hexane Fraction of cyperus rotundus Prevents Non-Alcoholic Fatty Liver Disease Through the Inhibition of Liver X Receptor α-Mediated Activation of Sterol Regulatory Element Binding Protein-1c.
    Oh GS; Yoon J; Lee GG; Kwak JH; Kim SW
    Am J Chin Med; 2015; 43(3):477-94. PubMed ID: 25967664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retinoic acid receptor-related orphan receptor α-induced activation of adenosine monophosphate-activated protein kinase results in attenuation of hepatic steatosis.
    Kim EJ; Yoon YS; Hong S; Son HY; Na TY; Lee MH; Kang HJ; Park J; Cho WJ; Kim SG; Koo SH; Park HG; Lee MO
    Hepatology; 2012 May; 55(5):1379-88. PubMed ID: 22183856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oleanolic Acid Inhibits Liver X Receptor Alpha and Pregnane X Receptor to Attenuate Ligand-Induced Lipogenesis.
    Lin YN; Chang HY; Wang CCN; Chu FY; Shen HY; Chen CJ; Lim YP
    J Agric Food Chem; 2018 Oct; 66(42):10964-10976. PubMed ID: 30351048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ursolic Acid, a Novel Liver X Receptor α (LXRα) Antagonist Inhibiting Ligand-Induced Nonalcoholic Fatty Liver and Drug-Induced Lipogenesis.
    Lin YN; Wang CCN; Chang HY; Chu FY; Hsu YA; Cheng WK; Ma WC; Chen CJ; Wan L; Lim YP
    J Agric Food Chem; 2018 Nov; 66(44):11647-11662. PubMed ID: 30359008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of liver X receptor-α-dependent hepatic steatosis by isoliquiritigenin, a licorice antioxidant flavonoid, as mediated by JNK1 inhibition.
    Kim YM; Kim TH; Kim YW; Yang YM; Ryu DH; Hwang SJ; Lee JR; Kim SC; Kim SG
    Free Radic Biol Med; 2010 Dec; 49(11):1722-34. PubMed ID: 20840863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of adenosine monophosphate-activated protein kinase-p70 ribosomal S6 kinase-1 pathway in repression of liver X receptor-alpha-dependent lipogenic gene induction and hepatic steatosis by a novel class of dithiolethiones.
    Hwahng SH; Ki SH; Bae EJ; Kim HE; Kim SG
    Hepatology; 2009 Jun; 49(6):1913-25. PubMed ID: 19378344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PPAR agonists reduce steatosis in oleic acid-overloaded HepaRG cells.
    Rogue A; Anthérieu S; Vluggens A; Umbdenstock T; Claude N; de la Moureyre-Spire C; Weaver RJ; Guillouzo A
    Toxicol Appl Pharmacol; 2014 Apr; 276(1):73-81. PubMed ID: 24534255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 22-S-Hydroxycholesterol protects against ethanol-induced liver injury by blocking the auto/paracrine activation of MCP-1 mediated by LXRα.
    Na TY; Han YH; Ka NL; Park HS; Kang YP; Kwon SW; Lee BH; Lee MO
    J Pathol; 2015 Apr; 235(5):710-20. PubMed ID: 25557254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Orphan nuclear receptor DAX-1 acts as a novel corepressor of liver X receptor alpha and inhibits hepatic lipogenesis.
    Nedumaran B; Kim GS; Hong S; Yoon YS; Kim YH; Lee CH; Lee YC; Koo SH; Choi HS
    J Biol Chem; 2010 Mar; 285(12):9221-32. PubMed ID: 20080977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver X receptor mediates hepatitis B virus X protein-induced lipogenesis in hepatitis B virus-associated hepatocellular carcinoma.
    Na TY; Shin YK; Roh KJ; Kang SA; Hong I; Oh SJ; Seong JK; Park CK; Choi YL; Lee MO
    Hepatology; 2009 Apr; 49(4):1122-31. PubMed ID: 19105208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histone H3K9 Demethylase JMJD2B Plays a Role in LXRα-Dependent Lipogenesis.
    Kim JH; Jung DY; Kim HR; Jung MH
    Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33167594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reciprocal regulation of LXRα activity by ASXL1 and ASXL2 in lipogenesis.
    Park UH; Seong MR; Kim EJ; Hur W; Kim SW; Yoon SK; Um SJ
    Biochem Biophys Res Commun; 2014 Jan; 443(2):489-94. PubMed ID: 24321552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-1 and microRNA-206 suppress LXRα-induced lipogenesis in hepatocytes.
    Zhong D; Huang G; Zhang Y; Zeng Y; Xu Z; Zhao Y; He X; He F
    Cell Signal; 2013 Jun; 25(6):1429-37. PubMed ID: 23499676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen receptor ligands ameliorate fatty liver through a nonclassical estrogen receptor/Liver X receptor pathway in mice.
    Han SI; Komatsu Y; Murayama A; Steffensen KR; Nakagawa Y; Nakajima Y; Suzuki M; Oie S; Parini P; Vedin LL; Kishimoto H; Shimano H; Gustafsson JÅ; Yanagisawa J
    Hepatology; 2014 May; 59(5):1791-802. PubMed ID: 24277692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor suppressor Menin acts as a corepressor of LXRα to inhibit hepatic lipogenesis.
    Cheng P; Li G; Yang SS; Liu R; Jin G; Zhou XY; Hu XG
    FEBS Lett; 2015 Oct; 589(20 Pt B):3079-84. PubMed ID: 25962847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of MIG12 as a mediator for stimulation of lipogenesis by LXR activation.
    Inoue J; Yamasaki K; Ikeuchi E; Satoh S; Fujiwara Y; Nishimaki-Mogami T; Shimizu M; Sato R
    Mol Endocrinol; 2011 Jun; 25(6):995-1005. PubMed ID: 21474539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic TRAP80 selectively regulates lipogenic activity of liver X receptor.
    Kim GH; Oh GS; Yoon J; Lee GG; Lee KU; Kim SW
    J Clin Invest; 2015 Jan; 125(1):183-93. PubMed ID: 25437875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.